Cargando…
Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?
In the present study we analyze the epidemiological data of COVID-19 of Tibet and high-altitude regions of Bolivia and Ecuador, and compare to lowland data, to test the hypothesis that high-altitude inhabitants (+2,500 m above sea-level) are less susceptible to develop severe adverse effects in acut...
Autores principales: | Arias-Reyes, Christian, Zubieta-DeUrioste, Natalia, Poma-Machicao, Liliana, Aliaga-Raduan, Fernanda, Carvajal-Rodriguez, Favio, Dutschmann, Mathias, Schneider-Gasser, Edith M., Zubieta-Calleja, Gustavo, Soliz, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175867/ https://www.ncbi.nlm.nih.gov/pubmed/32333993 http://dx.doi.org/10.1016/j.resp.2020.103443 |
Ejemplares similares
-
Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent
por: Arias-Reyes, Christian, et al.
Publicado: (2021) -
Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020) -
The Oxygen Transport Triad in High-Altitude Pulmonary Edema: A Perspective from the High Andes
por: Zubieta-Calleja, Gustavo, et al.
Publicado: (2021) -
Erythropoietin Produces a Dual Effect on Carotid Body Chemoreception in Male Rats
por: Arias-Reyes, Christian, et al.
Publicado: (2021) -
Pneumolysis and “Silent Hypoxemia” in COVID-19
por: Zubieta-Calleja, Gustavo, et al.
Publicado: (2020)